Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4832931, 6 pages
Review Article

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma

1Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, 10 East China Road, Nanning, Guangxi Zhuang Autonomous Region, China
2The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China

Correspondence should be addressed to JinYu Wu; moc.anis@9010uynijuw

Received 29 May 2017; Accepted 17 September 2017; Published 17 December 2017

Academic Editor: Francesco Marampon

Copyright © 2017 LongJiao Ran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Renal cell carcinoma (RCC) is the most common type of urinary malignancy. Clear cell renal cell carcinoma (ccRCC) is the predominant RCC subtype, accounting for 70–80% of RCC. In recent years, miRNAs have been found to be closely associated with the outcome of the patients with ccRCC. In this review, we summarize recent advances in research exploring the role of miRNAs in predicting prognosis in patients with ccRCC.